Latest News

Nov 25, 2021
Lytix Biopharma today releases its third quarter 2021 results
Nov 22, 2021
Lytix Biopharma will release its third quarter 2021 results on Thursday, 25 November
Nov 18, 2021
FDA has accepted Verrica's IND for LTX-315 in treatment of basal cell carcinoma
Nov 12, 2021
Lytix presents encouraging preclinical data in triple negative breast cancer in collaboration with Weill Cornell Medicine